A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM
Clinical trial NCT02766699 · COMPLETED
Trial details
- NCT number
- NCT02766699
- Sponsor
- Engeneic Pty Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-25
- Primary completion
- 2021-08-21
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.